Sun Pharma Advanced Research Com Q2 Results

  • BSE: 532872
  • NSE: SPARC
  • ISIN: INE232I01014
  • Sector: Business Services
BSE
201.55-2.85 (-1.39%)
Volume27.45 K
Updated: Mon 25 Nov, 2024 | 15:29:43
NSE
202.2-2.30 (-1.12%)
Volume4.80 L
Updated: Mon 25 Nov, 2024 | 15:42:01
Today: 200.75
207.95
52-Wk: 189.45
474.00

Q2 Results Highlights

  • Total Income
    ₹12.86 Cr.
    (-23.50%)
  • Operating Profit
    ₹-106.07 Cr.
    (8.37%)
  • Profit After Tax
    ₹-107.33 Cr.
    (10.83%)
  • Operating Margin
    -824.81%
    (84.57%)
Note: Comparison is on YoY basis

Quarterly - Sun Pharma Advanced Research Com Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 12.8623.95-%21.18-%
Selling/ General/ Admin Expenses Total 94.76109.45-%90.80-%
Depreciation/ Amortization 3.163.10-%3.18-%
Other Operating Expenses Total 12.7011.51-%15.38-%
Total Operating Expense 118.93129.23-%115.83-%
Operating Income -106.07-105.28-%-94.65-%
Net Income Before Taxes -107.17-95.35-%-86.42-%
Net Income -107.33-95.35-%-86.42-%
Diluted Normalized EPS -3.31-2.94-%-2.66-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts